V
vTv Therapeutics D
D
VTVT
16.300
USD
-0.56
(-3.32%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-6
حجم السوق
42,660,605
الأخبار المقالات
العنوان: vTv Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.